The brain in Down syndrome (TRISOMY 21)
- PMID: 12382149
- DOI: 10.1007/s00415-002-0799-9
The brain in Down syndrome (TRISOMY 21)
Abstract
Down syndrome (DS) is the most common genetic birth defect associated with mental retardation. The mechanism(s) underlying the neuropathology of DS is not completely understood. Different hypotheses have been advanced to explain this mystery, including the gene dosage effect, the amplified developmental instability, and the molecular misreading concept. Overexpression of genes residing in chromosome 21 has been assumed to be a central point in the neuropathology of DS, although reports disagreeing with this notion have also been published. In addition, an accumulating body of evidence indicates that genes located on other chromosomes are also involved in the process. DS thus appears to be a disease process involving numerous gene products and this interaction and interplay in the final analysis determines the outcome of the disease. In this regard, transcription factors, reactive oxygen species and apoptosis related proteins are viewed as potential candidates that play a significant role in the disease process. Therapeutic modalities that target these factors including antioxidants and caspase inhibitors might have some benefit in alleviating the symptoms of DS.
Similar articles
-
Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.Neurosci Res. 2007 Dec;59(4):349-69. doi: 10.1016/j.neures.2007.08.007. Epub 2007 Aug 15. Neurosci Res. 2007. PMID: 17897742 Review.
-
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).Amino Acids. 2003;24(1-2):111-7. doi: 10.1007/s00726-002-0336-2. Amino Acids. 2003. PMID: 12624742
-
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).Amino Acids. 2003;24(1-2):127-34. doi: 10.1007/s00726-002-0340-6. Amino Acids. 2003. PMID: 12624744
-
The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.J Neural Transm Suppl. 1999;57:293-303. J Neural Transm Suppl. 1999. PMID: 10666684 Review.
-
Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).Amino Acids. 2003;24(1-2):119-25. doi: 10.1007/s00726-002-0337-1. Amino Acids. 2003. PMID: 12624743
Cited by
-
Social abilities in young Mexicans with Down syndrome during the COVID-19 pandemic.Int J Dev Disabil. 2022 Feb 12;69(6):888-895. doi: 10.1080/20473869.2022.2038527. eCollection 2023. Int J Dev Disabil. 2022. PMID: 37885837 Free PMC article.
-
Dopey2 and Pcdh7 orchestrate the development of embryonic neural stem cells/ progenitors in zebrafish.iScience. 2023 Feb 25;26(3):106273. doi: 10.1016/j.isci.2023.106273. eCollection 2023 Mar 17. iScience. 2023. PMID: 36936789 Free PMC article.
-
Word prediction using closely and moderately related verbs in Down syndrome.Front Psychol. 2022 Oct 3;13:934826. doi: 10.3389/fpsyg.2022.934826. eCollection 2022. Front Psychol. 2022. PMID: 36262448 Free PMC article.
-
Epigenetic dysregulation in the developing Down syndrome cortex.Epigenetics. 2016 Aug 2;11(8):563-78. doi: 10.1080/15592294.2016.1192736. Epub 2016 May 31. Epigenetics. 2016. PMID: 27245352 Free PMC article.
-
Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease.J Alzheimers Dis. 2015;44(4):1107-20. doi: 10.3233/JAD-141254. J Alzheimers Dis. 2015. PMID: 25391381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
